Here are five orthopedic and sports medicine surgeons using Lipogems, an FDA-cleared technology that uses the body's own adipose tissue to help heal injuries.

Kuros Biosciences entered into a private label agreement with SeaSpine.

Robert Watkins Jr., MD, performed his first surgery with the Osseus Fusion Systems Aries-L technology, which is currently in alpha launch.

Ann Arbor-based Michigan Medicine researchers are working to improve the Masquelet orthopedic surgical technique, according to MHealth Lab.

Mark Miller, MD, is an orthopedic sports medicine surgeon and orthopedic surgery professor at the University of Virginia in Charlottesville.

Sirakoss received CE mark approval for its Osteo3, a new nano-synthetic bone graft substitute designed for use in bone fracture repair.

Seth L. Sherman, MD, enrolled and operated on four patients in a study of CartiHeal's Agili-C knee cartilage repair implant.  

Orthobiologics company Biogennix named Robert Bazier its new CFO.

Regenerative medicine company CollPlant appointed Jonathan M.N. Rigby as chairman of the board of directors.

Ortho Regenerative Technologies published the results of two scientific studies validating its product's ability to improve the repair of rotator cuff tendon and articular cartilage tissue.

The Pacific Brain Tumor Center at Santa Monica, Calif.-based Pacific Neuroscience Institute will serve as the leading enrollment site for Medicenna Therapeutics' clinical trial.

ThermoGenesis Corp. entered into a supply agreement with Los Angeles-based Orthohealing Center Management.

The CDC is investigating bacterial infections in patients who received stem cell treatments from the ReGen Series, distributed by Liveyon.

The global spine biologics market is expected to reach $2.7 billion by 2024, increasing at a 4.4 percent compound annual growth rate, according to a Data Bridge Market Research report.

Judge Brouck Jacobs ordered the Columbia-based University of Missouri to comply with a discovery request of its biojoint surgery records, according to the Columbia Tribune.

Japan approved Stemirac, a stem cell treatment for spinal cord injuries, Nature reports.

Asterias Biotherapeutics conducted a clinical trial to study the effectiveness of its OPC1 cells, Seeking Alpha reports. The company released its one-year results.

The American Association of Hip and Knee Surgeons does not currently recommend biologic treatments for advanced hip or knee arthritis, according to a new position statement.

Broomfield, Colo.-based Centeno-Schultz Clinic's Christopher J. Centeno, MD, is urging Colorado legislators to crackdown on unregulated stem cell treatments, The Denver Channel reports.

Rancho Mirage, Calif.-based Star Ortho is now offering Lipogems as an alternative or supplement to orthopedic surgery.